MB
Insider
Matthias Bodenstedt
Chief Financial OfficerMatthias Bodenstedt (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $1.6M of MLTX (85,870 sh × $18.94, as filed), executed Apr 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Jun 22
Filed Jun 23
Median ADV $19.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
MLTXRecent filings
MLTXSALE
MoonLake Immunotherapeutics
View filing →
$862K39,120 sh × $22.04
Exec Jun 22
Filed Jun 23 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics View filing → $297K
15,082 sh × $19.68
Exec Jun 17
Filed Jun 18 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics View filing → $273K
13,653 sh × $20.02
Exec May 11
Filed May 13 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics View filing → $1.6M
85,870 sh × $18.94
Exec Apr 9
Filed Apr 10 · 5:30 PM ET